Reducing the Time to Develop and Manufacture Formulations for First Oral Dose in Humans

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2003
Volume 27
Issue 10

The authors discuss approaches to delivering formulations fo first-time-in-human dosing.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content